Linked by Thom Holwerda on Mon 12th Mar 2012 19:04 UTC
Legal "Patent monopolies prevent innovation. It is a system that works against innovations, to protect the current corporations against competition from aggressive, innovative, and competitive upstarts. It allows the big corporations to crush competitive upstarts in the courtroom, rather than having to compete with their products and services." ...which happens to be exactly why the old boys' club of computer technology (Apple, Microsoft, Oracle, IBM) wants to keep it this way. This is not a system for the people, it's a system for huge corporations.
Thread beginning with comment 510387
To view parent comment, click here.
To read all comments associated with this story, please click here.
RE[2]: A first hand experience
by sid.art on Tue 13th Mar 2012 10:55 UTC in reply to "RE: A first hand experience"
sid.art
Member since:
2012-03-13

As far as "all of this anti-IP idealism does not apply to the pharma industry" type arguments go, i refer you to this :

levine.sscnet.ucla.edu/papers/imbookfinal09.pdf

It has me convinced.

Highlights the historical precedent for drugs-without-IP and the massive growth in the broader chemical industry in europe which was then lacking IP protection ( compared to the protected american industry )

Edited 2012-03-13 10:59 UTC

Reply Parent Score: 3